We will be conducting our annual physical inventory from March 11th through March 13th.

Orders received after 4pm CST on Tuesday, March 10th will be scheduled to ship as follows:

US Orders: Ship Saturday, March 14th for arrival on Monday, March 16th.
Canada Orders: Ship Monday, March 16th for arrival on Tuesday, March 17th.

Select items may ship earlier. For questions regarding the status of your order, contact custserv@promega.com.

pCMVTNT™ Vector

Instructions for Use of Product(s)
L5620

Literature # TB305

The pCMVTNT™ Vector is designed for convenient expression of cloned genes using in vivo or in vitro expression systems. Both the SP6 and T7 polymerase promoters lie in tandem adjacent to the multiple cloning site, allowing highly efficient synthesis of RNA in vitro from either promoter. Protein can be expressed in vitro from a gene cloned into the pCMVTNT™ Vector using an SP6- or T7-based in vitro transcription/translation system. The pCMVTNT™ Vector contains a 5´ β-globin leader sequence reported to enhance expression of certain genes in vitro. For in vivo expression, the vector contains a cytomegalovirus (CMV) enhancer/promoter region that allows strong constitutive expression in many cell types. A β-globin/IgG chimeric intron and a late SV40 polyadenylation site are located downstream from the enhancer/promoter region.

Summary of Changes: 9/14 Revision
The following change was made in the 9/14 revision of this document:
Patent and licensing information was updated.

Printed in USA. Revised 9/14.